Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets EXMKT - Delayed Quote USD

Imagenetix, Inc. (IAGX)

Compare
0.0002
-0.0028
(-93.33%)
At close: April 4 at 4:00:00 PM EDT
Loading Chart for IAGX
  • Previous Close 0.0030
  • Open 0.0002
  • Bid --
  • Ask --
  • Day's Range 0.0002 - 0.0002
  • 52 Week Range 0.0002 - 0.0002
  • Volume 48,186
  • Avg. Volume 0
  • Market Cap (intraday) 99,480
  • Beta (5Y Monthly) -511.31
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Imagenetix, Inc. develops, formulates, and markets proprietary and natural based nutritional supplements, and over-the-counter topical creams and skin care products. Its primary product is Celadrin, a product formulation for joint health. The company also licenses its intellectual property to third parties. Imagenetix, Inc. markets its products through various channels of distribution, including direct and mass marketing companies, nutritional newsletters, and medical and nutritional oriented professionals; medical newsletters; and direct response radio and television. The company was founded in 1996 and is based in San Diego, California.

www.imagenetix.net

5

Full Time Employees

March 31

Fiscal Year Ends

Recent News: IAGX

View More

Performance Overview: IAGX

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IAGX
0.00%
S&P 500 (^GSPC)
13.93%

1-Year Return

IAGX
0.00%
S&P 500 (^GSPC)
2.73%

3-Year Return

IAGX
60.00%
S&P 500 (^GSPC)
12.49%

5-Year Return

IAGX
90.48%
S&P 500 (^GSPC)
90.35%

Compare To: IAGX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IAGX

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    92.39k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: IAGX

View More

Company Insights: IAGX

Research Reports: IAGX

View More

People Also Watch